Major areas of activity
- Inflammation and Cardiovascular Disease (focus on RA and SLE and atherosclerosis)
- Cardiovascular Pharmacogenetics (focus on adrenergic receptor genetic variation)
- Pharmacogenetics and Drug Response (focus on warfarin and other drugs whose metabolism is affected by genetic variation, including ICU drugs, and statins)
- Drug Safety (focus on sudden death, opioids, and serious drug interactions.